DE60306517D1 - Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen - Google Patents
Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellenInfo
- Publication number
- DE60306517D1 DE60306517D1 DE60306517T DE60306517T DE60306517D1 DE 60306517 D1 DE60306517 D1 DE 60306517D1 DE 60306517 T DE60306517 T DE 60306517T DE 60306517 T DE60306517 T DE 60306517T DE 60306517 D1 DE60306517 D1 DE 60306517D1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- tumour
- tumor cells
- culture surface
- tumour markers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 4
- 210000004881 tumor cell Anatomy 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 abstract 7
- 210000004027 cell Anatomy 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 210000005266 circulating tumour cell Anatomy 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 239000000439 tumor marker Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0203136 | 2002-03-13 | ||
| FR0203136 | 2002-03-13 | ||
| PCT/FR2003/000806 WO2003076942A2 (fr) | 2002-03-13 | 2003-03-13 | Quantification de cellules tumorales circulantes issues de cancers solides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60306517D1 true DE60306517D1 (de) | 2006-08-10 |
| DE60306517T2 DE60306517T2 (de) | 2007-01-04 |
Family
ID=27799043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60306517T Expired - Lifetime DE60306517T2 (de) | 2002-03-13 | 2003-03-13 | Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050079557A1 (de) |
| EP (1) | EP1506407B1 (de) |
| JP (1) | JP4256265B2 (de) |
| AT (1) | ATE331958T1 (de) |
| AU (1) | AU2003242815A1 (de) |
| DE (1) | DE60306517T2 (de) |
| ES (1) | ES2268387T3 (de) |
| WO (1) | WO2003076942A2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2846426B1 (fr) | 2002-10-28 | 2004-12-10 | Bio Merieux | Procede de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie |
| JP4912894B2 (ja) | 2004-02-19 | 2012-04-11 | イェール ユニバーシティー | プロテオーム技術を使用した癌タンパク質バイオマーカーの同定 |
| CA2600225C (en) * | 2005-03-14 | 2016-06-28 | Immunivest Corporation | A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells |
| FR2896881B1 (fr) | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
| JP2009529880A (ja) * | 2006-03-13 | 2009-08-27 | ベリデックス・エルエルシー | 原発細胞の増殖 |
| WO2008029251A2 (en) * | 2006-09-07 | 2008-03-13 | Universitatsklinikum Hamburg-Eppendorf | Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells |
| GB0815675D0 (en) | 2008-08-28 | 2008-10-08 | Mabtech Ab | Antibody secreting cell elispot |
| EP2591363B1 (de) | 2010-07-07 | 2017-09-20 | The Regents Of The University Of Michigan | Diagnose und behandlung von brustkrebs |
| JP5804634B2 (ja) * | 2011-10-07 | 2015-11-04 | 久和 内山 | 植物栽培装置 |
| US9857360B2 (en) | 2013-01-25 | 2018-01-02 | Xcell Biosciences, Inc. | Cancer analysis system |
| FR3001805B1 (fr) | 2013-02-01 | 2015-02-20 | Biomerieux Sa | Procede de detection d'un cancer colorectal |
| CN106244553A (zh) * | 2015-10-22 | 2016-12-21 | 厦门人瑞生物医药科技有限公司 | 循环肿瘤细胞的分离和检测方法 |
| FR3050212B1 (fr) | 2016-04-15 | 2020-09-25 | Chu Montpellier | Procede de detection et/ou de caracterisation de cellules tumorales et appareil associe |
| JP2019158777A (ja) * | 2018-03-16 | 2019-09-19 | 東ソー株式会社 | 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL121659A (en) * | 1996-10-25 | 2000-07-16 | Bayer Ag | Method for determining CPSA in a blood sample |
| US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
| WO1999041613A1 (en) * | 1998-02-12 | 1999-08-19 | Immunivest | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
-
2003
- 2003-03-13 AU AU2003242815A patent/AU2003242815A1/en not_active Abandoned
- 2003-03-13 DE DE60306517T patent/DE60306517T2/de not_active Expired - Lifetime
- 2003-03-13 US US10/505,673 patent/US20050079557A1/en not_active Abandoned
- 2003-03-13 EP EP03743923A patent/EP1506407B1/de not_active Expired - Lifetime
- 2003-03-13 AT AT03743923T patent/ATE331958T1/de not_active IP Right Cessation
- 2003-03-13 JP JP2003575115A patent/JP4256265B2/ja not_active Expired - Lifetime
- 2003-03-13 ES ES03743923T patent/ES2268387T3/es not_active Expired - Lifetime
- 2003-03-13 WO PCT/FR2003/000806 patent/WO2003076942A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20050079557A1 (en) | 2005-04-14 |
| JP4256265B2 (ja) | 2009-04-22 |
| AU2003242815A1 (en) | 2003-09-22 |
| DE60306517T2 (de) | 2007-01-04 |
| AU2003242815A8 (en) | 2003-09-22 |
| ATE331958T1 (de) | 2006-07-15 |
| EP1506407A2 (de) | 2005-02-16 |
| WO2003076942A2 (fr) | 2003-09-18 |
| JP2005527793A (ja) | 2005-09-15 |
| ES2268387T3 (es) | 2007-03-16 |
| EP1506407B1 (de) | 2006-06-28 |
| WO2003076942A3 (fr) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mizutani et al. | Expression of somatostatin receptor (SSTR) subtypes (SSTR-1, 2A, 3, 4 and 5) in neuroendocrine tumors using real-time RT-PCR method and immunohistochemistry | |
| Gazzaniga et al. | Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis | |
| Zhang et al. | Tumor heterogeneity and circulating tumor cells | |
| Pham-Ledard et al. | Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma | |
| Park et al. | Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? | |
| Schnitt | Breast cancer in the 21st century: neu opportunities and neu challenges | |
| CA2699702A1 (en) | Cancer marker and therapeutic target | |
| DE60306517D1 (de) | Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen | |
| Hopkins et al. | Oncofetal gene SALL4 in aggressive hepatocellular carcinoma | |
| Maxwell et al. | A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors | |
| JP2006505793A (ja) | 膠芽腫の進行に関連する経路を試験するための方法及び材料 | |
| ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
| Mak et al. | Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells | |
| EP2473621A1 (de) | Verfahren und zusammensetzungen für den nachweis abgestorbener zellen und verwendungen davon | |
| Song et al. | Combined detection of HER2, Ki67, and GSTP1 genes on the diagnosis and prognosis of breast cancer | |
| Xu et al. | Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases | |
| Pillai et al. | Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model | |
| JP2012531612A5 (de) | ||
| CN102472753A (zh) | 基于组蛋白macroH2A同工型预测癌症复发风险的诊断方法 | |
| ATE545867T1 (de) | I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom | |
| ATE419533T1 (de) | Verfahren/präparat zur erkennung von pankreaskrebs | |
| Park et al. | Overexpression of neuron-specific enolase as a prognostic factor in patients with gastric cancer | |
| Wang et al. | Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance | |
| KR101238196B1 (ko) | 대장암의 간 전이 진단용 조성물 및 그 용도 | |
| WO2003068268A3 (en) | Treatment, diagnosis and imaging of disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: WITTE, WELLER & PARTNER, 70178 STUTTGART |